217
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Zerumbone binding to estrogen receptors: an in-silico investigation

, ORCID Icon, , &
Pages 342-351 | Received 23 Nov 2017, Accepted 21 Aug 2018, Published online: 05 Nov 2018

References

  • Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol Adv. 2015;33:1582–1614.
  • Azam F. Therapeutic potential of free radical scavengers in neurological disorders. In: Kozyrev D, Slutsky V, editors. Handbook of free radicals: formation, types and effects. New York: Nova Publishers; 2010. p. 57–97.
  • Azam F, Mohamed N, Alhussen F. Molecular interaction studies of green tea catechins as multitarget drug candidates for the treatment of Parkinson’s disease: computational and structural insights. Network. 2015;26:97–115.
  • Yob NJ, Jofrry SM, Affandi MM, et al. Zingiber zerumbet (L.) Smith: A review of its ethnomedicinal, chemical, and pharmacological uses. Evid Based Complement Alternat Med. 2011;2011:1.
  • Prasannan R, Kalesh KA, Shanmugam MK, et al. Key cell signaling pathways modulated by zerumbone: role in the prevention and treatment of cancer. Biochem Pharmacol. 2012;84:1268–1276.
  • Yodkeeree S, Sung B, Limtrakul P, et al. Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: evidence for an essential role of reactive oxygen species. Cancer Res. 2009;69:6581–6589.
  • Sung B, Jhurani S, Ahn KS, et al. Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells. Cancer Res. 2008;68:8938–8944.
  • Sehrawat A, Arlotti JA, Murakami A, et al. Zerumbone causes Bax- and Bak-mediated apoptosis in human breast cancer cells and inhibits orthotopic xenograft growth in vivo. Breast Cancer Res Treat. 2012;136:429–441.
  • Tanaka T, Shimizu M, Kohno H, et al. Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet. Life Sci. 2001;69:1935–1945.
  • Kim M, Miyamoto S, Yasui Y, et al. Zerumbone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice. Int J Cancer. 2009;124:264–271.
  • Abdelwahab SI, Abdul AB, Devi N, et al. Regression of cervical intraepithelial neoplasia by zerumbone in female Balb/c mice prenatally exposed to diethylstilboestrol: involvement of mitochondria-regulated apoptosis. Exp Toxicol Pathol. 2010;62:461–469.
  • Takada Y, Murakami A, Aggarwal BB. Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion. Oncogene. 2005;24:6957–6969.
  • Sakinah SA, Handayani ST, Hawariah LP. Zerumbone induced apoptosis in liver cancer cells via modulation of Bax/Bcl-2 ratio. Cancer Cell Int. 2007;7:4.
  • Hosoya T, Arai MA, Koyano T, et al. Naturally occurring small-molecule inhibitors of hedgehog/GLI-mediated transcription. Chembiochem. 2008;9:1082–1092.
  • Sung B, Murakami A, Oyajobi BO, et al. Zerumbone Abolishes RANKL-Induced NF-kappaB activation, inhibits osteoclastogenesis, and suppresses human breast cancer-induced bone loss in athymic nude mice. Cancer Res. 2009;69:1477–1484.
  • Russo J, Russo IH. Differentiation and breast cancer. Medicina (B Aires) 1997;57:81–91.
  • Haslam SZ, Counterman LJ, Nummy KA. Effects of epidermal growth factor, estrogen, and progestin on DNA synthesis in mammary cells in vivo are determined by the developmental state of the gland. J Cell Physiol. 1993;155:72–78.
  • Hilakivi-Clarke L, Clarke R, Lippman M. The influence of maternal diet on breast cancer risk among female offspring. Nutrition. 1999;15:392–401.
  • Liao DZ, Pantazis CG, Hou X, et al. Promotion of estrogen-induced mammary gland carcinogenesis by androgen in the male Noble rat: probable mediation by steroid receptors. Carcinogenesis. 1998;19:2173–2180.
  • Nuclear Receptors Nomenclature Commitee. A unified nomenclature system for the nuclear receptor superfamily [letter]. Cell. 1999;97:161–163.
  • Beato M, Herrlich P, Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell. 1995;83:851–857.
  • Hoffmann J, Sommer A. Anti-hormone therapy: principles of endocrine therapy of cancer. In: Bradbury RH, editor. Cancer. topics in medicinal chemistry. Vol. 1. Berlin, Heidelberg: Springer; 2006. p. 19–82.
  • Macgregor J, Jordan VC. Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev. 1998;50:151–196.
  • McGuire WL. Endocrine therapy of breast cancer. Annu Rev Med. 1975;26:353–363.
  • Peng J, Sengupta S, Jordan VC. Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer. Anticancer Agents Med Chem. 2009;9:481–499.
  • Martinkovich S, Shah D, Planey SL, et al. Selective estrogen receptor modulators: tissue specificity and clinical utility. Clin Interv Aging. 2014;9:1437–1452.
  • Bowers KJ, Chow E, Xu H, et al. 2006. Scalable algorithms for molecular dynamics simulations on commodity clusters. Proceedings of the ACM/IEEE Conference on Supercomputing (SC06), Tampa, Florida, November 11–17.
  • Desmond Molecular Dynamics System. 2016. D. E. Shaw Research, New York (NY), 2016. Maestro-Desmond Interoperability Tools, Schrödinger, New York (NY), 2016.
  • Harder E, Damm W, Maple J, et al. OPLS3: a force field providing broad coverage of drug-like small molecules and proteins. J Chem Theory Comput. 2016;12:281–296.
  • Hoover WG. Canonical dynamics: equilibrium phase-space distributions. Phys Rev A Gen Phys. 1985;31:1695–1697.
  • Martyna GJ, Tobias DJ, Klein ML. Constant pressure molecular dynamics algorithms. J Chem Phys. 1994;101:4177–4189.
  • Tuckerman M, Berne BJ, Martyna GJ. Reversible multiple time scale molecular dynamics. J Chem Phys. 1992;97:1990–2001.
  • Frisch MJ, Trucks GW, Schlegel HB, et al. 2010. Gaussian 09, revision E. 01. Wallingford (CT): Gaussian, Inc.
  • Wang R, Lu Y, Wang S. Comparative evaluation of 11 scoring functions for molecular docking. J Med Chem. 2003;46:2287–2303.
  • Azam F, Prasad MVV, Thangavel N. Structure-based design, synthesis and molecular modeling studies of 1-(benzo[d]thiazol-2-yl)-3-(substituted aryl)urea derivatives as novel anti-Parkinsonian agents. Med Chem Res. 2012;21:2630–2643.
  • Ahmed M, Azam F, Gbaj A, et al. Ester prodrugs of ketoprofen: synthesis, in vitro stability, in vivo biological evaluation and in silico comparative docking studies against COX-1 and COX-2. Curr Drug Discov Technol. 2016;13:41–57.
  • Hussain MS, Azam F, Ahamed KF, et al. Anti-endotoxin effects of terpenoids fraction from Hygrophila auriculata in lipopolysaccharide-induced septic shock in rats. Pharm Biol. 2016;54:628–636.
  • Shushni MA, Azam F, Lindequist U. Oxasetin from Lophiostoma sp. of the Baltic Sea: identification, in silico binding mode prediction and antibacterial evaluation against fish pathogenic bacteria. Nat Prod Commun. 2013;8:1223–1226.
  • Russo J, Russo IH. The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol. 2006;102:89–96.
  • Azam F, Amer AM, Abulifa AR, et al. Ginger components as new leads for the design and development of novel multi-targeted anti-Alzheimer’s drugs: a computational investigation. Drug Des Devel Ther. 2014;8:2045–2059.
  • Azam F. Ginger components as anti-Alzheimer drugs: focus on drug design. In: Farooqui T, Farooqui AA, editor. Neuroprotective effects of phytochemicals in neurological disorders. New Jersey: Wiley & Sons; 2017. p. 149–161.
  • Kaur G, Mahajan MP, Pandey MK, et al. Design, synthesis, and anti-breast cancer evaluation of new triarylethylene analogs bearing short alkyl- and polar amino-/amido-ethyl chains. Bioorg Med Chem Lett. 2016;26:1963–1969.
  • Nettles KW, Bruning JB, Gil G, et al. Structural plasticity in the oestrogen receptor ligand‐binding domain. EMBO Rep. 2007;8:563–568.
  • Pike AC. Lessons learnt from structural studies of the oestrogen receptor. Best Pract Res Clin Endocrinol Metab. 2006;20:1–14.
  • Haldosén LA, Zhao C, Dahlman-Wright K. Estrogen receptor beta in breast cancer. Mol Cell Endocrinol. 2014;382:665–672.
  • Maiorov VN, Crippen GM. Significance of Root-Mean-Square deviation in comparing three-dimensional structures of globular proteins. J Mol Biol. 1994;235:625–634.
  • Azam F, Alabdullah NH, Ehmedat HM, et al. NSAIDs as potential treatment option for preventing amyloid β toxicity in Alzheimer’s disease: an investigation by docking, molecular dynamics, and DFT studies. J Biomol Struct Dyn. 2018;36:2099–2117.
  • Franke R. 1984. Theoretical drug design methods. Amsterdam: Elsevier. p. 115–123.
  • Ośmiałowski K, Halkiewicz J, Radecki A, et al. Quantum chemical parameters in correlation analysis of gas-liquid chromatographic retention indices of amines. J Chromatogr A. 1985;346:53–60.
  • Zhou Z, Parr RG. Activation hardness: new index for describing the orientation of electrophilic aromatic substitution. J Am Chem Soc. 1990;112:5720–5724.
  • Latosińska JN, Latosińska M, Maurin JK, et al. Quantum-chemical insight into structure-reactivity relationship in 4,5,6,7-tetrahalogeno-1H-benzimidazoles: a combined X-ray, DSC, DFT/QTAIM, Hirshfeld surface-based, and molecular docking approach. J Phys Chem A. 2014;118:2089–2106.
  • Azam F, El-Gnidi BA, Alkskas IA. Combating oxidative stress in epilepsy: design, synthesis, quantum chemical studies and anticonvulsant evaluationof 1-(substituted benzylidene/ethylidene)-4-(naphthalen-1-yl) semicarbazides. Eur J Med Chem. 2010;45:2817–2826.
  • Aihara J. Reduced HOMO-LUMO gap as an index of kinetic stability for polycyclic aromatic hydrocarbons. J Phys Chem A. 1999;103:7487–7495.
  • Koopmans T. About the allocation of wave functions and eigenvalues of the individual electrons one atom. Physica 1934;1:104–113.
  • Parr RG, Szentpály LV, Liu S. Electrophilicity index. J Am Chem Soc. 1999;121:1922–1924.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.